# FDA recall D-0737-2022

> **Dr. Reddy's Laboratories, Inc.** · Class II · drug recall initiated 2022-03-23.

## Product

Lansoprazole Delayed-Release Capsules, USP, 15 mg, a) 30-count bottle, (NDC 55111-398-30), b) 90-count bottle, (55111-398-90), Rx Only, Manufactured. By: Dr. Reddy's Laboratories Limited, Bachupally - 500 090, India

## Reason for recall

Failed Dissolution Specifications; during long term stability testing.

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0737-2022
- **Recalling firm:** Dr. Reddy's Laboratories, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-03-23
- **Report date:** 2022-04-06
- **Termination date:** 2024-02-02

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Princeton, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0737-2022

## Citation

> AI Analytics. FDA recall D-0737-2022. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0737-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*